"10.1371_journal.pone.0147556","plos one","2016-01-25T00:00:00Z","Gil Amarilyo; Daniel E Furst; Jennifer M P Woo; Wen Li; Henning Bliddal; Robin Christensen; Simon Tarp","Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; David Geffen School of Medicine, University of California, Los Angeles, California, United States of America; Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark","Conceived and designed the experiments: GA DEF RC ST. Performed the experiments: GA ST. Analyzed the data: ST. Contributed reagents/materials/analysis tools: GA DEF JMPW WL HB RC ST. Wrote the paper: GA DEF JMPW WL HB RC.","G. Amarilyo, consulting fees: Novartis; Research grants: Novartis. S. Tarp, Research grants paid to institute: AbbVie, Bristol-Myers Squibb, Mundipharma, and Roche; Speakers bureau: AstraZeneca, Pfizer, and Norpharma. R. Christensen, Consulting fees paid to institute: Abbott/AbbVie, Axellus A/S, Bristol-Myers Squibb, Cambridge Weight Plan, MSD, Norpharma, Pfizer, and Roche; Axellus A/S, Cambridge Weight Plan, Mundipharma, and Roche; Research grants paid to institute: AbbVie, Axellus A/S, Bayer HealthCare Pharmaceuticals, Biogen Idec, Bristol-Myers Squibb, Cambridge Weight Plan, Ipsen, Laboratoires Expanscience, MSD, Mundipharma, Norpharma, Pfizer, Roche, and Wyeth. D. E. Furst, Research grants: AbbVie, Actelion, Amgen, BMS, Gilead, GSK, NIH, Novartis, Pfizer, Roche/Genentech, UCB; Consulting fees or other remuneration (payment): AbbVie, Actelion, Amgen, BMS, Janssen, Gilead, GSK, NIH, Novartis, Pfizer, Roche/Genentech, UCB; Speakers bureau: AbbVie, Actelion, and UCB. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","01","Gil Amarilyo","GA",7,TRUE,4,2,1,6,TRUE,FALSE,FALSE,0,NA,FALSE
